Cardiovascular Journal of Africa: Vol 26 No 2 Supplement (March/April 2015)

S48

AFRICA

CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015

Dis

2013;

(3): 251–260.

58. Chen G, Adeyemo A, Zhou J, Chen Y, Huang H, Doumatey A,

et al.

Genome-wide search for susceptibility genes to type 2 diabetes in West

Africans: potential role of C-peptide.

Diabetes Res Clin Pract

2007;

(3): e1–6.

59. Ovbiagele B. Impairment in glomerular filtration rate or glomerular

filtration barrier and occurrence of stroke.

Arch Neurol

2008;

(7):

934–938.

60. Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden

DW,

et al

MYH9

is a major-effect risk gene for focal segmental glomer-

ulosclerosis

. Nat Genet

2008;

(10): 1175–1184.

61. Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P,

Freedman BI,

et al.

Association of trypanolytic ApoL1 variants with

kidney disease in African Americans.

Science

2010;

329

(5993): 841–845.

62. Tayo BO, Kramer H, Salako BL, Gottesman O, McKenzie CA,

Ogunniyi A,

et al.

Genetic variation in APOL1 and MYH9 genes

is associated with chronic kidney disease among Nigerians.

Int Urol

Nephrol

2013;

(2): 485–494.

63. Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A,

et al.

Missense mutations in the

APOL1

gene are highly associated with end-

stage kidney disease risk previously attributed to the

MYH9

gene.

Hum

Genet

2010;

128

(3): 345–350.

64. Bentley AR, Doumatey AP, Chen G, Huang H, Zhou J, Shriner D,

al.

Variation in APOL1 Contributes to Ancestry-Level Differences in

HDLc-Kidney Function Association.

Int J Nephrol

2012;

2012

: 748984.

65. Van der Sijde MR, Ng A, Fu J. Systems genetics: From GWAS to

disease pathways.

Biochim Biophys Acta

2014;

1842

(10): 1903–1909.

66. Atwood LD, Wolf PA, Heard-Costa NL, Massaro JM, Beiser A,

D’Agostino RB,

et al.

Genetic variation in white matter hyperintensity

volume in the Framingham Study

. Stroke

2004;

(7): 1609–1613.

67. Moskau S, Golla A, Grothe C, Boes M, Pohl C, Klockgether T.

Heritability of carotid artery atherosclerotic lesions: an ultrasound study

in 154 families

. Stroke

2005;

(1): 5–8. Epub 2004 Nov 29.

68. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y.

Complications associated with sickle cell trait: a brief narrative review.

Am J Med

2009;

122

(6): 507–512.

69. Piel FB, atil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN,

al.

Global distribution of the sickle cell gene and geographical confirma-

tion of the malaria hypothesis

. Nat Commun

2010;

: 104.

70. Lemos Cardoso G, Farias Guerreiro J. African gene flow to north Brazil

as revealed by HBB*S gene haplotype analysis.

Am J Hum Biol

006;

(1): 93–98.

71. Osuntokun BO, Osuntokun O.

omplicated migraine and haemoglobin

AS in Nigerians.

Br Med J

1972;

(5814): 621–622.

72. Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S,

Moohr JW,

et al

. Cerebrovascular accidents in sickle cell disease: rates

and risk factors.

Blood

1998;

(1): 288–294.

73. Flanagan JM, Frohlich DM, Howard TA, Schultz WH, Driscoll C,

Nagasubramanian R,

et al.

Genetic predictors for stroke in children with

sickle cell anemia.

Blood

2011;

117

(24): 6681–6684.

74. Flanagan JM, heehan V, Linder H, Howard TA, Wang YD, Hoppe CC,

et al

. Genetic mapping and exome sequencing identify 2 mutations asso-

ciated with stroke protection in pediatric patients with sickle cell anemia

Blood

2013;

121

(16): 3237–3245.

75. Ruchoux MM, Maurage CA. CADASIL: Cerebral autosomal domi-

nant arteriopathy with subcortical infarcts and leukoencephalopathy.

Neuropathol Exp Neurol

1997;

(9): 947–964.

76. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN. Review:

molecular genetics and pathology of hereditary small vessel diseases of

the brain.

Neuropathol Appl Neurobiol

2011;

(1): 94–113.

77. Lee SJ, Meng H, Elmadhoun O, Blaivas M, Wang MM. Cerebral

autosomal dominant arteriopathy with subcortical infarcts and leukoen-

cephalopathy affecting an African American man: identification of a

novel 15-base pair NOTCH3 duplication

Arch Neurol

2011;

(12):

1584–1586.

78. Meschia JF, Worrall BB, Rich SS. Genetic susceptibility to ischemic

stroke.

Nat Rev Neurol

2011;

(7): 369–378.

79. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK,

et al

. Multilocus linkage identifies two new loci for a Mendelian form

of stroke, cerebral cavernous malformation, at

7p15-13

and

3q25.2-27

Hum Mol Genet

1998;.

(12): 1851–1858.

80. Janunger T, Nilsson-Ardnor S, Wiklund PG, Lindgren P, Escher SA,

Lackovic K,

et al.

A novel stroke locus identified in a northern Sweden

pedigree: linkage to chromosome 9q31-33.

Neurology

2009;

(21):

1767–1773.

81. Nilsson-Ardnor S, Janunger T, Wiklund PG, Lackovic K, Nilsson AK,

Lindgren P,

et al

. Genome-wide linkage scan of common stroke in fami-

lies from northern Sweden.

Stroke

2007;

(1): 34–40.

82. Wang XY, Wang JW, Tang X, Li N, Chen DF, Wu YQ,

et al.

Linkage

and association between interleukin-6 gene polymorphisms and ischem-

ic stroke: a family-based study in the northern Chinese Han population.

Genet Test Mol Biomarkers

2014;

(11): 761–766.

83. Liu B, Zhang L, Yang Q. Genetics of intracerebral hemorrhage: Insights

from candidate gene approaches.

Neurol India

2012;

(1): 3–8.

84. Biffi A, Anderson CD, Jagiella JM, Schmidt H, Kissela B, Hansen BM,

et al.

APOE genotype and extent of bleeding and outcome in lobar

intracerebral haemorrhage: a genetic association study.

Lancet Neurol

2011;

(8): 702–709.

85. Brouwers HB, Biffi A, Ayres AM, Schwab K, Cortellini L, Romero JM,

et al

. Apolipoprotein E genotype predicts hematoma expansion in lobar

intracerebral hemorrhage

. Stroke

2012;

(6): 1490–1495.

86. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN.

Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and

cerebrovascular pathology associated with Alzheimer’s disease.

Am J

Pathol

1996;

148

(6): 2083–2095.

87. Kalaria RN, Ogeng’o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM,

et al.

Evaluation of risk factors for Alzheimer’s disease in elderly east

Africans.

Brain Res Bull

1997;

(5): 573–577.

88. Dichgans M, Markus HS. Genetic association studies in stroke: meth-

odological issues and proposed standard criteria.

Stroke

2005;

(9):

2027–2031. Epub 2005 Jul 28.

89. Meschia JF. Stroke genome-wide association studies: the large numbers

imperative.

Stroke

2010;

(4): 579–580.

90. Markus HS, Alberts MJ. Update on genetics of stroke and cerebrovascu-

lar disease 2005

. Stroke

2006;

(2): 288–290. Epub 2006 Jan 12.

91. Meschia JF, Nalls M, Matarin M, Brott TG, Brown RD Jr, Hardy J,

. Siblings with ischemic stroke study: results of a genome-wide scan for

stroke loci.

Stroke

2011;

(10): 2726–2732.

92. Hata J, Kubo M, Kiyohara Y. [Genome-wide association study for

ischemic stroke based on the Hisayama study].

Nihon Eiseigaku Zasshi

2011;

(1): 47–52.

93. Matarin M, Brown WM, Dena H, Britton A, De Vrieze FW, Brott TG,

et al.

Candidate gene polymorphisms for ischemic stroke.

Stroke

2009;

(11): 3436–3442.

94. Gretarsdottir S, Thorleifsson G, Manolescu A, Styrkarsdottir U,

Helgadottir A, Gschwendtner A,

et al.

Risk variants for atrial fibrilla-

tion on chromosome 4q25 associate with ischemic stroke.

Ann Neurol

2008;

(4): 402–409.

95. Gudbjartsson DF, Holm H, Gretarsdottir S, Thorleifsson G, Walters

GB, Thorgeirsson G,

et al.

A sequence variant in ZFHX3 on 16q22